Hemoadsorption in critically ill patients with or without COVID-19 : A word of caution

Putzu, Alessandro; Schorer, Raoul

doi:10.1016/j.jcrc.2021.06.007

Scientific article

Comment

English

Hemoadsorption in critically ill patients with or without COVID-19 : A word of caution

ContributorsPutzu, Alessandro

; Schorer, Raoul

Published inJournal of critical care, vol. 65, p. 140-141

Publication date2021-10

First online date2021-06-12

Abstract

Comment on : Schädler D, Pausch C, Heise D, Meier-Hellmann A, Brederlau J, Weiler N, Marx G, Putensen C, Spies C, Jörres A, Quintel M, Engel C, Kellum JA, Kuhlmann MK. The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial. PLoS One. 2017 Oct 30;12(10):e0187015. doi: 10.1371/journal.pone.0187015. PMID: 29084247; PMCID: PMC5662220.

Keywords

ARDS
COVID-19
Cytokine
Cytosorb®
Hemoadsorption
Hemoperfusion
Mortality
Randomized trial
Safety
Sepsis

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département d'anesthésiologie, pharmacologie, soins intensifs et urgences

Citation (ISO format)

PUTZU, Alessandro, SCHORER, Raoul. Hemoadsorption in critically ill patients with or without COVID-19 : A word of caution. In: Journal of critical care, 2021, vol. 65, p. 140–141. doi: 10.1016/j.jcrc.2021.06.007

Article (Published version)

CC BY-NC-ND-4.0

Identifiers

PID : unige:192125
DOI : 10.1016/j.jcrc.2021.06.007
PMID : 34148009
PMCID : PMC8196317

Additional URL for this publicationhttps://www.sciencedirect.com/science/article/pii/S0883944121001180

Journal ISSN0883-9441

5views

56downloads

Creation18/02/2026 01:35:29

First validation10/03/2026 08:02:23

Update10/03/2026 08:02:23

Status update10/03/2026 08:02:23

Last indexation10/03/2026 08:02:25

Archive ouverte UNIGE

Hemoadsorption in critically ill patients with or without COVID-19 : A word of caution

Technical informations